Pharmaceuticals

Transfection Technologies Market 2026–2030: Forecasting Business Opportunities Ahead

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the transfection technologies market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Transfection Technologies Market’s size between 2026 and 2030?

The transfection technologies market has experienced robust growth in recent years. It is anticipated to increase from $1.31 billion in 2025 to $1.42 billion in 2026, at a compound annual growth rate (CAGR) of 8.8%. This historical expansion is attributable to several factors, including the rising interest in molecular biology research, significant developments in gene expression studies, the growing demand for protein production, enhanced financial support for genomics research, and its initial integration into academic laboratories.

The transfection technologies market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $1.99 billion, exhibiting a compound annual growth rate (CAGR) of 8.7%. This projected growth is driven by factors such as the expansion of cell and gene therapies, the increasing number of RNA therapeutics in development, greater investment in life sciences research, the need for effective transfection reagents, and the broader application of personalized medicine. Key trends expected during this period encompass a growing need for gene editing research instruments, the widespread development of RNA-based therapeutics, more extensive adoption in cell and gene therapy, an increase in academic and biomedical research activities, and ongoing progress in non-viral transfection techniques.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

Which Drivers Are Shaping Strategic Decisions In The Transfection Technologies Market?

The increasing adoption of gene therapy is anticipated to boost the expansion of the transfection technologies market in the future. Gene therapy represents a method focused on addressing or preventing illnesses through genetic alterations, encompassing the insertion, correction, or substitution of defective genes. The growing prominence of gene therapy stems from advancements in genetic research, improved delivery techniques, and its capability to manage genetic conditions that were formerly untreatable. Transfection technologies play a vital role in gene therapy by enabling the accurate, secure, and efficient introduction of genetic material into cellular structures. These technologies enable both transient and lasting alterations to the genome, which are fundamental for addressing genetic disorders and various cancers. As an illustration, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, reported that the Food and Drug Administration (FDA) sanctioned six gene therapy products in 2023, an increase from five approvals recorded in 2022. Consequently, the expansion of gene therapy is propelling the growth of the transfection technologies market.

What Segment Categories Are Covered In The Transfection Technologies Market?

The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

How Are New Market Trends Shaping The Landscape Of The Transfection Technologies Market?

Leading companies in the transfection technologies market are prioritizing the development of advanced systems, such as mechanoporation transfection systems, to enable more intricate and personalized applications in both research and therapeutics. These mechanoporation systems function by utilizing mechanical forces to create temporary openings in cell membranes, allowing genetic material to enter the cells. This method demonstrates efficiency and minimal invasiveness, contributing to better preservation of cell viability. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology firm, unveiled CellPore, an innovative transfection system. This system comprises a benchtop unit and the CellPore Transfection Kit 300, which includes a specialized reagent kit and single-use delivery cartridges. By employing controlled, rapid deformation within microfluidic channels, CellPore effectively introduces small molecules, nucleic acids, proteins, and gene editing complexes into cells, ensuring minimal cell disruption and high viability. These attributes are crucial for advancing research and the progression of cutting-edge cell and gene therapies.

Which Major Firms Are Strengthening Their Position In The Transfection Technologies Market?

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

Which Region Shows The Strongest Potential For Future Expansion In The Transfection Technologies Market?

North America was the largest region in the transfection technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Transfection Technologies Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp

Browse Through More Reports Similar to the Global Transfection Technologies Market 2026, By The Business Research Company

Transfection Reagents And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/transfection-reagents-and-equipment-global-market-report

Gene Delivery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

Sterilization Equipment And Disinfectants Market 2026

https://www.thebusinessresearchcompany.com/report/sterilization-equipment-and-disinfectants-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795